PLYX Polaryx Therapeutics, Inc.

Fundamentals / CIK 0002075320 / USD

Polaryx Therapeutics, Inc. reported $8.61M in total assets and a net loss of $8.75M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PLYX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$28.38MFY 2024 Net Income: -$30.36M2024FY 2025 Net Income: -$8.98M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development $6.27M $2.81M
Total Operating Expenses $7.82M $4.35M
Operating Income -$7.82M -$4.35M
Income Before Tax -$8.98M -$30.36M
Net Income -$8.98M -$30.36M
Basic EPS -$0.20 -$0.89
Diluted EPS -$0.20 -$0.89
Basic Shares Outstanding 45.4M 34.2M
Diluted Shares Outstanding 45.4M 34.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $2.45M $719K $679K $560K $514K $476K $4.72M
Total Operating Expenses $3.33M $1.38M $1.96M $911K $974K $884K $5.05M
Operating Income -$3.33M -$1.38M -$1.96M -$911K -$974K -$884K -$5.05M
Net Income -$3.33M -$1.38M -$2.54M -$1.50M -$1.43M -$1.01M -$5.05M
Basic EPS -$0.07 -$0.03 -$0.05 -- -$0.03 -$0.02 -$0.11
Diluted EPS -$0.07 -$0.03 -$0.05 -- -$0.03 -$0.02 -$0.11
Basic Shares Outstanding 49.8M 48.3M 47.2M -- 45.8M 44.7M 44.3M
Diluted Shares Outstanding 49.8M 48.3M 47.2M -- 45.8M 44.7M 44.3M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $5.14M $4.62M
Cash & Short-Term Investments $5.14M $4.62M
Other Current Assets $27K --
Total Current Assets $5.17M $5.00M
Total Non-Current Assets $0 $0
Total Assets $5.17M $5.00M
Accounts Payable $470K $72K
Total Current Liabilities $605K $289K
Total Non-Current Liabilities $0 $0
Total Liabilities $605K $289K
Common Stock $5.0K $4.0K
Retained Earnings -$99.64M -$90.65M
Total Stockholders' Equity $4.57M $4.71M
Total Equity $4.57M $4.71M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2024-12-31
Cash & Cash Equivalents $8.44M $11.54M $3.08M $5.14M $4.62M
Cash & Short-Term Investments $8.44M $11.54M $3.08M $5.14M $4.62M
Other Current Assets $18K -- $33K $27K --
Total Current Assets $8.61M $11.81M $3.50M $5.17M $5.00M
Total Non-Current Assets $0 $0 $0 $0 $0
Total Assets $8.61M $11.81M $3.50M $5.17M $5.00M
Accounts Payable $783K $683K $850K $470K $72K
Total Current Liabilities $999K $873K $1.01M $605K $289K
Total Non-Current Liabilities $0 $0 $0 $0 $0
Total Liabilities $999K $873K $1.01M $605K $289K
Common Stock $5.0K $5.0K $5.0K $5.0K $4.0K
Retained Earnings -$106.9M -$103.6M -$102.2M -$99.64M -$90.65M
Total Stockholders' Equity $7.61M $10.94M $2.49M $4.57M $4.71M
Total Equity $7.61M $10.94M $2.49M $4.57M $4.71M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$8.98M -$30.36M
Stock-Based Compensation $4.72M $2.40M
Change in Payables $398K -$401K
Operating Cash Flow -$3.94M -$2.57M
Common Stock Issued $4.49M $7.32M
Financing Cash Flow $4.47M $7.19M
Net Change in Cash $522K $4.62M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$3.33M -$1.38M -$2.54M -$1.50M -$1.43M -$1.01M -$5.05M
Stock-Based Compensation $0 $0 $467K $57K $108K $109K $4.45M
Change in Payables $100K -$167K $380K -$26K $338K $103K -$17K
Operating Cash Flow -$3.10M -$1.37M -$2.06M -$1.49M -$887K -$858K -$709K
Common Stock Issued -- -- -- $759K $3.48M $0 $250K
Financing Cash Flow -- -- -- $888K $3.33M $0 $250K
Net Change in Cash -$3.10M $8.46M -$2.06M -$602K $2.44M -$858K -$459K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Equity (ROE) -196.8% -644.2%
Return on Assets (ROA) -173.8% -607.0%
Current Ratio 8.55x 17.30x
Quick Ratio 8.50x 15.99x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Return on Equity (ROE) -114.9% -62.6% -260.3% -196.8% -- -- --
Return on Assets (ROA) -101.6% -58.0% -185.0% -173.8% -- -- --
Current Ratio 8.62x 13.53x 3.45x 8.55x -- -- --
Quick Ratio 8.45x 13.22x 3.04x 8.50x -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002075320) · from December 31, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal